Anterior segment mesenchymal dysgenesis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Anterior segment mesenchymal dysgenesis | |
|---|---|
| Synonyms | Anterior segment dysgenesis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Corneal opacity, glaucoma, iris abnormalities |
| Complications | Vision impairment, blindness |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutations affecting eye development |
| Risks | Family history of the condition |
| Diagnosis | Clinical examination, genetic testing |
| Differential diagnosis | Peters anomaly, Axenfeld-Rieger syndrome |
| Prevention | N/A |
| Treatment | Surgical intervention, glaucoma management |
| Medication | N/A |
| Prognosis | Variable, depending on severity and treatment |
| Frequency | Rare |
| Deaths | N/A |
Anterior segment mesenchymal dysgenesis (ASMD) is a rare congenital disorder that affects the development of the front part of the eye. This condition is characterized by abnormalities in the cornea, iris, and other structures that make up the anterior segment of the eye.
Etiology[edit]
ASMD is caused by mutations in the PITX3 gene, which is involved in the early development of the eye. This gene provides instructions for making a protein that regulates the activity of other genes. Mutations in the PITX3 gene disrupt the normal development of the anterior segment, leading to the features of ASMD.
Clinical Features[edit]
The clinical features of ASMD can vary widely, even among members of the same family. Common features include corneal opacity, iris hypoplasia (underdevelopment of the iris), and cataract. Some affected individuals may also have glaucoma, a condition that increases pressure in the eye and can lead to vision loss.
Diagnosis[edit]
Diagnosis of ASMD is based on the clinical features and confirmed by genetic testing to identify mutations in the PITX3 gene.
Treatment[edit]
Treatment for ASMD is symptomatic and supportive. It may include surgery to remove cataracts or to treat glaucoma. Regular eye examinations are recommended to monitor the condition and to detect and treat any complications as early as possible.
Prognosis[edit]
The prognosis for individuals with ASMD depends on the severity of the condition and the presence of any complications. With appropriate treatment and management, most individuals with ASMD can maintain a good quality of life.
See Also[edit]
- Congenital disorder
- Eye
- PITX3 gene
- Corneal opacity
- Iris hypoplasia
- Cataract
- Glaucoma
- Genetic testing
- Surgery
- Eye examination
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

